RESUMEN
Guillain-Barré syndrome/Miller-Fisher syndrome (GBS/MFS) overlap syndrome is an extremely rare variant of Guillain-Barré syndrome (GBS) in which Miller-Fisher syndrome (MFS) coexists with other characteristics of GBS, such as limb weakness, paresthesia, and facial paralysis. We report the clinical case of a 12-year-old patient, with no pathological history, who acutely presents with ophthalmoplegia, areflexia, facial diplegia, and swallowing and phonation disorders, followed by progressive, descending, and symmetrical paresis affecting first the upper limbs and then the lower limbs. An albuminocytological dissociation was found in the cerebrospinal fluid study. Magnetic resonance imaging of the spinal cord showed enhancement and thickening of the cauda equina roots. The patient was treated with immunoglobulins with a favorable clinical outcome.
Asunto(s)
Síndrome de Guillain-Barré , Imagen por Resonancia Magnética , Síndrome de Miller Fisher , Humanos , Síndrome de Miller Fisher/diagnóstico , Síndrome de Miller Fisher/fisiopatología , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/fisiopatología , Síndrome de Guillain-Barré/complicaciones , Síndrome de Guillain-Barré/terapia , Niño , Masculino , Inmunoglobulinas/administración & dosificación , Resultado del TratamientoRESUMEN
Fisher syndrome is recognized as a variant of Guillain-Barré syndrome, encompassing acute onset immune-mediated neuropathies marked by the classical triad of ataxia, areflexia, and ophthalmoplegia. Generally, Fisher syndrome follows a self-limited course with a good prognosis. Ophthalmoplegia, typically bilateral, progresses to complete external ophthalmoplegia within 1-2 weeks. Ataxia, often very severe, may cause an inability to walk without support despite normal strength. Fisher syndrome is also frequently concomitant with additional clinical features, including ptosis, internal ophthalmoplegia, facial nerve palsy, sensory deficits, and bulbar palsy. The confirmation of an antecedent infection is often established. Among the ganglioside antibodies, anti-GQ1b antibodies exhibit positivity in over 80% of patients. The syndrome manifests in three distinct types: a partial subtype exhibiting only a subset of the triad symptoms, Bickerstaff's brainstem encephalitis marked by impaired consciousness and pyramidal tract signs, and an overlapping subtype with Guillain-Barré syndrome, characterized by weakness in the extremities.
Asunto(s)
Síndrome de Miller Fisher , Humanos , Síndrome de Miller Fisher/diagnóstico , Síndrome de Miller Fisher/inmunología , Síndrome de Miller Fisher/terapia , Síndrome de Miller Fisher/fisiopatología , Gangliósidos/inmunología , Pronóstico , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/terapiaRESUMEN
BACKGROUND & PURPOSE: In this retrospective study, we aimed at defining the clinical, paraclinical and outcome features of acute neurological syndromes associated with anti-GQ1b antibodies. RESULTS: We identified 166 patients with neurological symptoms appearing in less than 1 month and anti-GQ1b antibodies in serum between 2012 and 2022. Half were female (51%), mean age was 50 years (4-90), and the most frequent clinical features were areflexia (80% of patients), distal upper and lower limbs sensory symptoms (78%), ophthalmoplegia (68%), sensory ataxia (67%), limb muscle weakness (45%) and bulbar weakness (45%). Fifty-three patients (32%) presented with complete (21%) and incomplete (11%) Miller Fisher syndrome (MFS), thirty-six (22%) with Guillain-Barre syndrome (GBS), one (0.6%) with Bickerstaff encephalitis (BE), and seventy-three (44%) with mixed MFS, GBS & BE clinical features. Nerve conduction studies were normal in 46% of cases, showed demyelination in 28%, and axonal loss in 23%. Anti-GT1a antibodies were found in 56% of cases, increased cerebrospinal fluid protein content in 24%, and Campylobacter jejuni infection in 7%. Most patients (83%) were treated with intravenous immunoglobulins, and neurological recovery was complete in 69% of cases at 1 year follow-up. One patient died, and 15% of patients relapsed. Age > 70 years, initial Intensive Care Unit (ICU) admission, and absent anti-GQ1b IgG antibodies were predictors of incomplete recovery at 12 months. No predictors of relapse were identified. CONCLUSION: This study from Western Europe shows acute anti-GQ1b antibody syndrome presents with a large clinical phenotype, a good outcome in 2/3 of cases, and frequent relapses.
Asunto(s)
Autoanticuerpos , Gangliósidos , Síndrome de Miller Fisher , Humanos , Femenino , Masculino , Persona de Mediana Edad , Adulto , Gangliósidos/inmunología , Anciano , Estudios Retrospectivos , Adulto Joven , Adolescente , Autoanticuerpos/sangre , Autoanticuerpos/líquido cefalorraquídeo , Anciano de 80 o más Años , Síndrome de Miller Fisher/fisiopatología , Síndrome de Miller Fisher/sangre , Síndrome de Miller Fisher/diagnóstico , Niño , Preescolar , Síndrome de Guillain-Barré/sangre , Síndrome de Guillain-Barré/fisiopatología , Síndrome de Guillain-Barré/diagnóstico , Síndrome de Guillain-Barré/inmunologíaRESUMEN
La encefalitis de tallo cerebral es un síndrome que se presenta con alteración del estado de conciencia, oftalmoplejia, ataxia y signos piramidales. Esta condición neurológica rara que fue descrita en 1950 por primera vez, presenta similares características clínicas a Síndrome de Guillain-Barré, por lo que representa un reto diagnóstico para el clínico. En este artículo se presenta el caso clínico de una paciente de 51 años de edad que se presenta con alteración del estado de conciencia, es llevada a unidad de cuidado intensivo de adulto donde se considera el diagnóstico de encefalitis de Bickerstaff, tras un exhaustivo abordaje diagnostico; el cual se describe, al igual que sumanejo y evolución...(AU)
Brain stem encephalitis is a syndrome that presents with altered state of consciousness, ophthalmoplegia, ataxia and pyramidal signs. This rare neurological condition that was described in1950 by The first time, it presents similar clinical characteristics to Guillain-Barré syndrome, which represents a diagnostic challenge for the clinician. This article presents the clinical case of a 51-year-old patient who presents with altered state of consciousness, is taken to the adult intensive care unit where the diagnosis of Bickerstaff encephalitis is considered, after an exhaustive diagnostic approach ; which is described, as well as its management and evolution ... (AU)
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Tronco Encefálico/patología , Síndrome de Miller Fisher/fisiopatología , Síndrome de Guillain-Barré/tratamiento farmacológico , Encefalitis Infecciosa/tratamiento farmacológico , Espectroscopía de Resonancia Magnética/métodos , Técnicas de Laboratorio Clínico/métodosRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto , Síndrome de Miller Fisher/fisiopatología , Examen Neurológico/métodos , Infecciones por Campylobacter/complicaciones , Fenómenos Fisiológicos del Sistema Nervioso , Campylobacter/patogenicidadRESUMEN
El síndrome de Ross fue descrito en 1958 como una afección degenerativa del sistema nervioso autónomo definido por la tríada de anhidrosis generalizada, disminución de los reflejos tendinosos y pupila tónica. Desde su descripción inicial se han descrito cerca de cuarenta casos. Comunicamos tres pacientes con variantes de interés que incluyen la presencia de espasmos cíclicos espontáneos del esfínter de iris, el desarrollo conjunto de síndrome de Holmes-Adie en un lado y síndrome Horner posganglionar en el otro, trastornos del desarrollo piloso en el lado de la anhidrosis, alteraciones de la motilidad intestinal, lengua sin papilas gustativas y disfunción sexual.
Ross Syndrome was described in 1958 as a degenerative condition of the autonomic nervous system defined by a triad of generalized anhidrosis, reduction of tendon reflexes and tonic pupil. Since its initial description about 40 cases have been described. We communicate three cases with variants of interest involving the presence of the simultaneous development of syndrome of Holmes-Adie on one side and Horner syndrome in the other, disorders of pilous follicle development on the side of anhidrosis, spontaneous disturbances of intestinal motility, tonque without papillae and sexual dysfunction.
Asunto(s)
Humanos , Masculino , Adulto , Femenino , Persona de Mediana Edad , Cefalea/diagnóstico , Degeneración Nerviosa/patología , Enfermedades Neurodegenerativas/patología , Enfermedades del Iris/patología , Hiperhidrosis/patología , Hipoestesia/diagnóstico , Nervio Oculomotor/anatomía & histología , Pupila Tónica/diagnóstico , Síndrome de Horner/patología , Síndrome de Miller Fisher/fisiopatología , Agudeza Visual/fisiología , Anisocoria/fisiopatología , Biopsia/métodos , Blefaroptosis/etiología , Midriasis/fisiopatologíaRESUMEN
JUSTIFICATIVA E OBJETIVOS: A síndrome de Miller Fisher apresenta a tríade oftalmoplegia, ataxia e arreflexia e, em muitas situações pode ser confundida com a doença de Guillian-Barré ou com a encefalite de Bickerstaff, em que ocorre um acometimento dos níveis de consciência. O objetivo deste estudo foi alertar para o possível diagnóstico de Miller Fisher, uma variante da síndrome de Guillain-Barré, abordando algumas recentes descobertas envolvidas com sua fisiopatologia como também, considerando alguns dos seus principais diagnósticos diferenciais. CONTEÚDO: A presença de anticorpos IgG anti-GQ1b pode ser um mecanismo importante na fisiopatologia da síndrome, porém ainda há controvérsias, desde que a simples presença desses anticorpos não garante o aparecimento da síndrome e alguns nervos em que se encontram depósitos desses anticorpos não apresentam alterações. Infecções respiratórias ou do trato gastrintestinal pregressas podem ser encontradas em 70% dos casos de Miller Fisher o que sugere um processo imunológico com reação cruzada aos agentes etiológicos dessas condições clínicas. CONCLUSÃO: A identificação precoce do quadro e o tratamento com gamaglobulina e/ou plasmaférese pode modificar em muito a evolução do quadro e permitir um prognóstico mais favorável, mesmo que ainda não se saiba o real processo fisiopatológico envolvido nessa doença.
BACKGROUND AND OBJECTIVES: Miller Fisher syndrome comes with ophtalmoplegia, ataxia, and arreflexia and, in many situations, has a similar presentation as Guillain-Barré syndrome or Bickerstaff disease. In this last condition, loss of conscious nessmay be present. In this review we were warning for a possible Miller Fisher syndrome, a Guillain-Barre syndrome variant,showing some news pathophysiology aspects and some differentials diagnosis. CONTENTS: IgG anti GQb1 antibodies can play an important role in the pathophysiology but controversies exist, since the presence of these antibodies does not guarantee the presence of the disease. Some peripheral nerves where antibodies are deposited do not present alterations. Respiratory or gastrointestinal tract infections may precede Miller Fisher in 70% of the cases,suggesting that an immunologic cross reaction can trigger thesyndrome. CONCLUSION: The precocious identification of this clinical picture as well an early treatment with gammaglobulin and or plasmapheresis can deeply modify the progression of the disease and allow a much better prognosis.
Asunto(s)
Humanos , Polineuropatías , Síndrome de Miller Fisher/diagnóstico , Síndrome de Miller Fisher/fisiopatología , Diagnóstico DiferencialRESUMEN
No disponible